Sign up
Pharma Capital

Lancor Scientific offering a 'tangible solution to a real problem' in healthcare

Proactive Investors sits down with Lancor Scientific's chief operating officer Gopal Gao and SVP of Engineering Nick Holmes.

Lancor along with Tumour Trace are looking to roll out their cancer screening device, initially in India, early next year.

 

View full LANCO profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.